UnitedHealth Faces Criminal Probe for Medicare Fraud, Shares Plunge

Criminal Probe and Share Plunge

• 📉 UnitedHealth shares hit a 5-year low following a Wall Street Journal report alleging a criminal probe by the DOJ.
• ⚠️ The company denies being notified of a probe, calling the report "deeply irresponsible" and noting the exact nature of allegations is unclear.
• 📉 This news compounds recent headwinds, including a management shakeup and suspended guidance, leading to investor concerns.

Medicare Advantage Business Challenges

• 🎯 Investors are concerned about higher-than-expected medical costs within UnitedHealth's Medicare Advantage business.
• 💰 The company needs to address pricing issues in these plans for 2026.
• 🩺 These challenges have also impacted its Optum health physician practices.

Regulatory and Legal Pressures

• ⚖️ The Trump administration is advancing an FTC lawsuit against the Optum Pharmacy benefits unit and other PBMs.
• 💊 Proposed curbs in a recent drug price executive order and the Biden administration's opposition to a $3.3 billion deal for Amedis add to regulatory pressure.
• 🚨 The DOJ is already pursuing billing fraud charges against other companies like Elevance, Humana, and CVS's Aetna for Medicare overpayments.

Market Reaction and Confidence

• 📊 Despite analysts expecting a bottom, UNH shares tumbled to lows not seen since April 2020.
• 📉 The company's price-to-earnings ratio is now just over 10 times estimated earnings, especially after withdrawing guidance.
• 🤝 UnitedHealth has significant ground to cover to restore investor confidence.

Broader Industry Pressures

• 🏥 Rivals are also under pressure, partly due to the GOP's proposed $625 billion in cuts to Medicaid.
• 👥 These Medicaid cuts could potentially remove over seven and a half million people from the rolls, impacting companies like Centene and Humana.